*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Iloperidone is a second-generation antipsychotic agent primarily manufactured via <strong>condensation reactions</strong> involving specific heterocyclic precursors. Its chemical structure is defined by the molecular formula <strong>C24H27FN4O2</strong> and CAS Registry Number <strong>106913-58-2</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Active Pharmaceutical Ingredient (API) production for treating schizophrenia.</li>
<li><strong>Formulation Development:</strong> Used in immediate-release tablet manufacturing processes.</li>
<li><strong>Research & Development:</strong> Utilized in clinical trials for evaluating efficacy against positive and negative symptoms.</li>
</ul>
<h3>Precautions</h3>
<p>Strict adherence to Good Manufacturing Practices (GMP) is required during synthesis. The API must be stored in a cool, dry environment below 25°C, protected from light and moisture. Clinical use necessitates monitoring for QTc interval prolongation and metabolic side effects.</p>